Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Somerset Therapeutics Private Limited | Bengaluru, India | Makes it, tests it, packages it and labels it | Serious problems, FDA actionFeb 21, 2025 · 10 inspections, 4 with FDA action |
Recalls
- Mar 21, 2025 · Class II · Somerset Therapeutics Private Limited
Lack of Assurance of Sterility: Media fill with bacterial contamination
Lots: NDC 70069-101-25; A240304, A240305, A240320, A240322, A240334, A240335, A240340, exp. date 05/2026; A240342, A240347, A240385, A240391, exp. date 06/2026; NDC 70069-101-05; A240326, exp. date 05/2026
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Methocarbamol: every company that makes it
- Form
- injection, intramuscular; intravenous
- Strength
- 100 mg per 1 mL
- Approval
- ANDA ANDA207522
- On the market since
- Jul 31, 2017
- Package NDCs
70069-101-0570069-101-1070069-101-25- Official label
- DailyMed (National Library of Medicine), updated Mar 22, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?